University Hospital

Medicine & Life Sciences

1. Neoplasms 100%
2. Non-Small Cell Lung Carcinoma 86%
3. Japan 84%
4. Therapeutics 73%
5. Lung Neoplasms 55%
6. Lung 54%
7. Drug Therapy 52%
8. Mutation 45%
9. Breast Neoplasms 45%
10. Survival 44%
11. Recurrence 43%
12. Neoplasm Metastasis 42%
13. Kidney 40%
14. Tomography 39%
15. Tibial Meniscus 36%
16. Serum 35%
17. ErbB Receptors 35%
18. Lung Transplantation 34%
19. Cisplatin 34%
20. Genes 33%
21. Hepatocellular Carcinoma 33%
22. Radiofrequency Ablation 32%
23. Bone and Bones 30%
24. Transplants 28%
25. Living Donors 28%
26. Small Cell Lung Carcinoma 27%
27. Cell Line 27%
28. Liver Transplantation 27%
29. Liver 26%
30. Gefitinib 26%
31. Prostatic Neoplasms 26%
32. Magnetic Resonance Imaging 25%
33. Confidence Intervals 25%
34. Safety 25%
35. Stomach Neoplasms 24%
36. Biopsy 24%
37. Retrospective Studies 23%
38. Prospective Studies 22%
39. Carcinoma 22%
40. Adenoviridae 21%
41. Chemoradiotherapy 21%
42. Diabetic Nephropathies 21%
43. Incidence 20%
44. Cohort Studies 20%
45. Pediatrics 20%
46. Tooth 20%
47. Radiotherapy 20%
48. Wounds and Injuries 19%
49. Multicenter Studies 19%
50. Lymph Nodes 19%
51. Seizures 18%
52. Tears 18%
53. Progression-Free Survival 18%
54. Odds Ratio 18%
55. Apoptosis 18%
56. Child 18%
57. Stomach 18%
58. Proteins 18%
59. Hemorrhage 18%
60. Atrial Heart Septal Defects 17%
61. Squamous Cell Carcinoma 17%
62. Aneurysm 17%
63. Stroke 17%
64. Docetaxel 17%
65. Elderly 17%
66. Stents 17%
67. Tissue Donors 16%
68. Biomarkers 16%
69. Colorectal Neoplasms 16%
70. Thorax 16%
71. Eye 16%
72. Endoscopic Mucosal Resection 16%
73. Protein-Tyrosine Kinases 16%
74. Brain 16%
75. Messenger RNA 15%
76. Pharmaceutical Preparations 15%
77. Growth 15%
78. Randomized Controlled Trials 15%
79. Survival Rate 15%
80. Knee 14%
81. Electroencephalography 14%
82. Cytokines 14%
83. Gene Expression 14%
84. Hematopoietic Stem Cell Transplantation 14%
85. Lymphoma 14%
86. Adenocarcinoma of Lung 14%
87. Hepatectomy 14%
88. Skin 14%
89. Infections 14%
90. Telomerase 14%
91. Esophageal Neoplasms 14%
92. Urinary Bladder Neoplasms 14%
93. Pancreatic Neoplasms 13%
94. In Vitro Techniques 13%
95. Injections 13%
96. Alzheimer Disease 13%
97. Renal Cell Carcinoma 13%
98. Antibodies 13%
99. Multivariate Analysis 13%
100. Pathologic Constriction 13%